Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study

被引：0

作者：

Muchtar, Eli ^{[1
]}

Palladini, Giovanni ^{[2
]}

Schonland, Stefan ^{[3
]}

Dispenzieri, Angela ^{[4
]}

Wisniowski, Brendan ^{[5
]}

Merlini, Giampaolo ^{[2
,6
]}

Milani, Paolo ^{[7
,8
]}

Hegenbart, Ute ^{[9
]}

Dittrich, Tobias ^{[10
]}

Kastritis, Efstathios ^{[11
]}

Dimopoulos, Meletios Athanasios ^{[12
]}

Sanchorawala, Vaishali ^{[13
,14
]}

Szalat, Raphael E. ^{[13
,14
]}

Liedtke, Michaela ^{[15
]}

Gupta, Mani ^{[16
]}

Landau, Heather ^{[17
]}

Lentzsch, Suzanne ^{[18
]}

Hughes, Michael Sang ^{[19
]}

Cibeira Lopez, Maria Teresa ^{[20
]}

Blade, Joan ^{[21
]}

Kumar, Shaji Kunnathu ^{[22
]}

Wechalekar, Ashutosh D. ^{[23
]}

Gertz, Morie A. ^{[4
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

[3] Heidelberg Univ, Heidelberg, Germany

[4] Mayo Clin, Rochester, MN USA

[5] UCL, Royal Free Hosp Campus, Natl Amyloidosis Ctr, London, England

[6] Univ Pavia, Pavia, Italy

[7] Univ Pavia, Dept Mol Med, Pavia, Italy

[8] Fdn IRCCS Policlinico San Matteo, Pavia, Italy

[9] Univ Heidelberg Hosp, Internal Med Hematol Oncol & Rheumatol 5, Neckargemund, Germany

[10] Heidelberg Univ, Med Dept 5, Amyloidosis Ctr, Heidelberg, Germany

[11] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[12] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece

[13] Boston Univ Chobanian & Avedisian Sch Med, Sect Hematol & Med Oncol, Dept Med, Boston, MA USA

[14] Boston Med Ctr, Boston, MA USA

[15] Stanford Univ Sch Med, Div Hematol, Dept Med, Stanford, CA USA

[16] Stanford Univ, Stanford Amyloid Ctr, Stanford, CA USA

[17] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[18] Columbia Univ Med Ctr, Div Hematol & Oncol, New York, NY USA

[19] Columbia Univ Med Ctr, New York, NY USA

[20] Univ Barcelona, Barcelona, Spain

[21] Hosp Clin Barcelona, IDIBAPS, Amyloidosis & Multiple Myeloma Unit, Dept Hematol, Barcelona, Spain

[22] Mayo Clin, Div Hematol, Rochester, MN USA

[23] Univ Coll London Hosp, London, England

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190226

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[41] Natriuretic Peptides and Cardiac Troponins: Markers of Disease Progression and Risk in Light Chain Cardiac Amyloidosis
Isabel Wees
Nicholas S. Hendren
Gurbakhash Kaur
Lori R. Roth
Justin L. Grodin
[J]. Current Heart Failure Reports, 2023, 20 : 350 - 357
[42] Natriuretic Peptides and Cardiac Troponins: Markers of Disease Progression and Risk in Light Chain Cardiac Amyloidosis
Wees, Isabel
Hendren, Nicholas S.
Kaur, Gurbakhash
Roth, Lori R.
Grodin, Justin L.
[J]. CURRENT HEART FAILURE REPORTS, 2023, 20 (05) : 350 - 357
[43] Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progression
Basset, Marco
Hummedah, Kamal
Kimmich, Christoph
Veelken, Kaya
Dittrich, Tobias
Brandelik, Simone
Kreuter, Michael
Hassel, Jessica
Bosch, Nikolaus
Stuhlmann-Laeisz, Christiane
Blank, Norbert
Mueller-Tidow, Carsten
Roecken, Christoph
Hegenbart, Ute
Schoenland, Stefan
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (10) : 1158 - 1169
[44] Hepatic Involvement as the Sole Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis: A Diagnostic Challenge
Kottavadakkeel, Nadeer
Rajaram, Arun
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
[45] HEPATIC AMYLOIDOSIS (PRIMARY [AL], IMMUNOGLOBULIN LIGHT CHAIN) - THE NATURAL-HISTORY IN 80 PATIENTS
GERTZ, MA
KYLE, RA
[J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (01): : 73 - 80
[46] Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient
Nakano, Ryosuke
Ohira, Masahiro
Ide, Kentaro
Ishiyama, Kohei
Kobayashi, Tsuyoshi
Tahara, Hiroyuki
Tashiro, Hirotaka
Kuroda, Yoshiaki
Ichinohe, Tatsuo
Arihiro, Koji
Chayama, Kazuaki
Ohdan, Hideki
[J]. HEPATOLOGY RESEARCH, 2015, 45 (10) : E150 - E155
[47] Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure
Oye, Monique
Sanders, Kimberly
Ghali, Maged
Alkhasawneh, Ahmad
[J]. BMJ CASE REPORTS, 2020, 13 (06)
[48] Incidence and prevalence of light chain amyloidosis: a population-based study
Mohty, D.
Duhamel, S.
Magne, J.
Lavergne, D.
Bordessoule, D.
Aboyans, V.
Guthrie, S.
Jaccard, A.
[J]. EUROPEAN HEART JOURNAL, 2018, 39 : 380 - 380
[49] Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Mollenhauer, Brit
Dakna, Mohammed
Kruse, Niels
Galasko, Douglas
Foroud, Tatiana
Zetterberg, Henrik
Schade, Sebastian
Gera, Roland G.
Wang, Wenting
Gao, Feng
Frasier, Mark
Chahine, Lana M.
Coffey, Christopher S.
Singleton, Andrew B.
Simuni, Tanya
Weintraub, Daniel
Seibyl, John
Toga, Arthur W.
Tanner, Caroline M.
Kieburtz, Karl
Marek, Kenneth
Siderowf, Andrew
Cedarbaum, Jesse M.
Hutten, Samantha J.
Trenkwalder, Claudia
Graham, Danielle
[J]. MOVEMENT DISORDERS, 2020, 35 (11) : 1999 - 2008
[50] Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study
Duhamel, Suzanne
Mohty, Dania
Magne, Julien
Lavergne, David
Bordessoule, Dominique
Aboyans, Victor
Jaccard, Arnaud
[J]. BLOOD, 2017, 130

← 1 2 3 4 5 →